JPMorgan Lowers GSK Price Target, Maintains Underweight Rating
On October 31, JPMorgan lowered its price target on GSK plc (NYSE:GSK) to 1,440 GBp from 1,550 GBp while maintaining an Underweight rating on the stock, according to a report by The...







